Loading...

Gregory Bean, MD, PhD

TitleHS Clinical Instructor
InstitutionUniversity of California San Francisco
DepartmentPathology
Address1825 4th Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bean G, Joseph NM, Folpe AL, Horvai AE, Umetsu SE. Recurrent GNA14 mutations in anastomosing hemangiomas. Histopathology. 2018 Mar 25. PMID: 29574926.
      View in: PubMed
    2. Bean G, Wen KW, Horvai AE. Adipocyte size variability in benign and malignant lipomatous tumors and morphologic mimics: a quantitative definition using digital pathology. Hum Pathol. 2018 Feb; 72:52-58. PMID: 29128479.
      View in: PubMed
    3. Krings G, Bean G, Chen YY. Fibroepithelial lesions; The WHO spectrum. Semin Diagn Pathol. 2017 Sep; 34(5):438-452. PMID: 28688536.
      View in: PubMed
    4. Krings G, Joseph NM, Bean G, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol. 2017 Aug; 30(8):1086-1099. PMID: 28548128.
      View in: PubMed
    5. Bean G, Joseph NM, Gill RM, Folpe AL, Horvai AE, Umetsu SE. Recurrent GNAQ mutations in anastomosing hemangiomas. Mod Pathol. 2017 May; 30(5):722-727. PMID: 28084343.
      View in: PubMed
    6. Baker JC, Ostrander JH, Lem S, Broadwater G, Bean G, D'Amato NC, Goldenberg VK, Rowell C, Ibarra-Drendall C, Grant T, Pilie PG, Vasilatos SN, Troch MM, Scott V, Wilke LG, Paisie C, Rabiner SM, Torres-Hernandez A, Zalles CM, Seewaldt VL. ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):1884-90. PMID: 18708376; PMCID: PMC2717700.
    7. Bean G, Ibarra Drendall C, Goldenberg VK, Baker JC, Troch MM, Paisie C, Wilke LG, Yee L, Marcom PK, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Scott V, Seewaldt VL. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):50-6. PMID: 17220331.
      View in: PubMed